Bruce Jackson
Stock Analyst at Benchmark
(1.07)
# 3,867
Out of 5,149 analysts
124
Total ratings
30.09%
Success rate
-18.57%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $5 → $14 | $5.33 | +162.66% | 2 | Dec 31, 2025 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $113.61 | +27.63% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.89 | +207.33% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.07 | +1,208.41% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.57 | +430.50% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.03 | +556.06% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.58 | +791.47% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $167.88 | -52.35% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.54 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $103.37 | -37.12% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.20 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.78 | +342.48% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.28 | +344.05% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.00 | +200.96% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.05 | +376.28% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $13.74 | +2,083.41% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $4.74 | +1,165.82% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.22 | +7,795.96% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.79 | +2,945.69% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.17 | +2,876.19% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.08 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $18.92 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.62 | +30,428.53% | 1 | Aug 8, 2022 |
CapsoVision
Dec 31, 2025
Maintains: Speculative Buy
Price Target: $5 → $14
Current: $5.33
Upside: +162.66%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $113.61
Upside: +27.63%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.89
Upside: +207.33%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.07
Upside: +1,208.41%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.57
Upside: +430.50%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.03
Upside: +556.06%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.58
Upside: +791.47%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $167.88
Upside: -52.35%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.54
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $103.37
Upside: -37.12%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.20
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.78
Upside: +342.48%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.28
Upside: +344.05%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.00
Upside: +200.96%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.05
Upside: +376.28%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $13.74
Upside: +2,083.41%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $4.74
Upside: +1,165.82%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.22
Upside: +7,795.96%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.79
Upside: +2,945.69%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.17
Upside: +2,876.19%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.08
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $18.92
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.62
Upside: +30,428.53%